Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
McKesson
Argus Health
McKinsey
US Army
Moodys
US Department of Justice
Cerilliant
Citi

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019369

« Back to Dashboard

NDA 019369 describes TEGISON, which is a drug marketed by Roche and is included in one NDA. Additional details are available on the TEGISON profile page.

The generic ingredient in TEGISON is etretinate. Additional details are available on the etretinate profile page.
Summary for 019369
Tradename:TEGISON
Applicant:Roche
Ingredient:etretinate
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 019369

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength10MG
Approval Date:Sep 30, 1986TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength25MG
Approval Date:Sep 30, 1986TE:RLD:No

Expired US Patents for NDA 019369

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche TEGISON etretinate CAPSULE;ORAL 019369-002 Sep 30, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Roche TEGISON etretinate CAPSULE;ORAL 019369-001 Sep 30, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Roche TEGISON etretinate CAPSULE;ORAL 019369-002 Sep 30, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Roche TEGISON etretinate CAPSULE;ORAL 019369-001 Sep 30, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Julphar
UBS
Moodys
McKesson
Dow
McKinsey
Queensland Health
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.